✦ LIBER ✦

Lipid-modifying efficacy of extended release niacin/laropiprant in Asian patients with primary hypercholesterolemia or mixed hyperlipidemia

✍ Scribed by Debra Kush; Hyo-Soo Kim; Da Yi Hu; Ji Liu; Waheeda Sirah; Aditi Sapre; Christine McCrary Sisk; John F. Paolini; Darbie Maccubbin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid-modifying efficacy and tolerabilit

✍ D. Maccubbin; H. E. Bays; A. G. Olsson; V. Elinoff; A. Elis; Y. Mitchel; W. Sira 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

Efficacy and safety of extended-release

✍ S. Shah; R. Ceska; B. Gil-Extremera; J. F. Paolini; H. Giezek; K. Vandormael; A. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

LIPID-ALTERING EFFICACY AND SAFETY PROFI

✍ Farnier, M.; Ose, L.; Gleim, G.; Liu, N.; Thompson-Bell, S.; Beckey, K.; Johnson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Lipid-Altering Efficacy and Safety of Ez

✍ John R. Guyton; B. Greg Brown; Sergio Fazio; Adam Polis; Joanne E. Tomassini; An 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 463 KB

EFFICACY AND SAFETY OF EZETIMIBE/SIMVAST

✍ FAZIO, S; BROWN, B; GUYTON, J; POLIS, A; TOMASSINI, J; TERSHAKOVEC, A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 170 KB

170: Attainment of lipid targets after n

📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 90 KB